SPOTLIGHT: Device makers team up on stent safety study
Earlier this year, medical device giants Johnson & Johnson and Boston Scientific were involved in a knock-down, drag out fight over the acquisition of Guidant. But in light of recent reports that blood clots can form within drug-coated stents, the former rivals as well as several other device makers have come together to fund a 10,000-person study of the technology. Report
Be the first to comment
Comments
Post new comment
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
- Forecast Model: Antidyslipidemics - Genericization and negative trial data drive market shrinkage
